10:57 AM EST - OpSens Inc. : Announced newly published data supporting the correlation between OpSens' OptoWire, powered by Fidela™ sensor, and a novel transcatheter aortic valve replacement (TAVR) interface, with measurement derived from standard hemodynamic assessment, both before and after TAVR. OpSens Inc.
shares T.OPS are trading unchanged at $1.82.
